Scientific consultation on immunological correlates of protection induced by dengue vaccines. Report from a meeting held at the World Health Organization 17-18 November 2005

Joachim Hombach, M. Jane Cardosa, Arunee Sabchareon, David W. Vaughn, Alan Barrett

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Several dengue vaccine candidates have been evaluated in early clinical phase, and some are scheduled for efficacy testing in population-based studies. Given the advancements in dengue vaccine development, there is an increased interest in identifying immunological correlates of protection for these vaccines in order to facilitate their evaluation, further refinement, production and registration. To this end, the WHO Initiative for Vaccine Research (IVR) convened a consultation on primary and secondary immunological correlates of protection induced by dengue vaccines. The meeting was held on the 17th and 18th of November, 2005 at WHO headquarters in Geneva. The consultation was a first dedicated review of the available data in support of establishing correlates. It is concluded that it is not yet possible to define one specific set of correlates, the consultation concluded in recommendations that should help to gather the missing evidence in conjunction with future vaccine trials.

Original languageEnglish (US)
Pages (from-to)4130-4139
Number of pages10
JournalVaccine
Volume25
Issue number21
DOIs
StatePublished - May 22 2007

Fingerprint

Dengue Vaccines
dengue
World Health Organization
Referral and Consultation
Vaccines
vaccines
vaccine development
Research
Population

Keywords

  • Correlates
  • Dengue
  • Immunity
  • Vaccine

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)

Cite this

Scientific consultation on immunological correlates of protection induced by dengue vaccines. Report from a meeting held at the World Health Organization 17-18 November 2005. / Hombach, Joachim; Jane Cardosa, M.; Sabchareon, Arunee; Vaughn, David W.; Barrett, Alan.

In: Vaccine, Vol. 25, No. 21, 22.05.2007, p. 4130-4139.

Research output: Contribution to journalArticle

@article{399ed0763fb342999887920813a55d91,
title = "Scientific consultation on immunological correlates of protection induced by dengue vaccines. Report from a meeting held at the World Health Organization 17-18 November 2005",
abstract = "Several dengue vaccine candidates have been evaluated in early clinical phase, and some are scheduled for efficacy testing in population-based studies. Given the advancements in dengue vaccine development, there is an increased interest in identifying immunological correlates of protection for these vaccines in order to facilitate their evaluation, further refinement, production and registration. To this end, the WHO Initiative for Vaccine Research (IVR) convened a consultation on primary and secondary immunological correlates of protection induced by dengue vaccines. The meeting was held on the 17th and 18th of November, 2005 at WHO headquarters in Geneva. The consultation was a first dedicated review of the available data in support of establishing correlates. It is concluded that it is not yet possible to define one specific set of correlates, the consultation concluded in recommendations that should help to gather the missing evidence in conjunction with future vaccine trials.",
keywords = "Correlates, Dengue, Immunity, Vaccine",
author = "Joachim Hombach and {Jane Cardosa}, M. and Arunee Sabchareon and Vaughn, {David W.} and Alan Barrett",
year = "2007",
month = "5",
day = "22",
doi = "10.1016/j.vaccine.2007.02.079",
language = "English (US)",
volume = "25",
pages = "4130--4139",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "21",

}

TY - JOUR

T1 - Scientific consultation on immunological correlates of protection induced by dengue vaccines. Report from a meeting held at the World Health Organization 17-18 November 2005

AU - Hombach, Joachim

AU - Jane Cardosa, M.

AU - Sabchareon, Arunee

AU - Vaughn, David W.

AU - Barrett, Alan

PY - 2007/5/22

Y1 - 2007/5/22

N2 - Several dengue vaccine candidates have been evaluated in early clinical phase, and some are scheduled for efficacy testing in population-based studies. Given the advancements in dengue vaccine development, there is an increased interest in identifying immunological correlates of protection for these vaccines in order to facilitate their evaluation, further refinement, production and registration. To this end, the WHO Initiative for Vaccine Research (IVR) convened a consultation on primary and secondary immunological correlates of protection induced by dengue vaccines. The meeting was held on the 17th and 18th of November, 2005 at WHO headquarters in Geneva. The consultation was a first dedicated review of the available data in support of establishing correlates. It is concluded that it is not yet possible to define one specific set of correlates, the consultation concluded in recommendations that should help to gather the missing evidence in conjunction with future vaccine trials.

AB - Several dengue vaccine candidates have been evaluated in early clinical phase, and some are scheduled for efficacy testing in population-based studies. Given the advancements in dengue vaccine development, there is an increased interest in identifying immunological correlates of protection for these vaccines in order to facilitate their evaluation, further refinement, production and registration. To this end, the WHO Initiative for Vaccine Research (IVR) convened a consultation on primary and secondary immunological correlates of protection induced by dengue vaccines. The meeting was held on the 17th and 18th of November, 2005 at WHO headquarters in Geneva. The consultation was a first dedicated review of the available data in support of establishing correlates. It is concluded that it is not yet possible to define one specific set of correlates, the consultation concluded in recommendations that should help to gather the missing evidence in conjunction with future vaccine trials.

KW - Correlates

KW - Dengue

KW - Immunity

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=34247337264&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247337264&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2007.02.079

DO - 10.1016/j.vaccine.2007.02.079

M3 - Article

VL - 25

SP - 4130

EP - 4139

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 21

ER -